Mohammed Dagher leads projects in the field of Real-World Evidence (RWE), epidemiological and clinical trials. In the RWE, he is responsible for designing and implementing secondary data-driven non-interventional studies. His duties include developing medical algorithms and interpreting big medical data sets for secondary data projects. These projects cover diverse topics such as Epidemiology, HEOR, Safety, and a broad range of therapy areas. In the epidemiological studies, he manages different non-interventional, observational studies in various therapeutic areas according to international standards.
His interdisciplinary experience comprises medical/pharmaceutical expertise and advanced project management skills. In addition, he is a practitioner clinical pharmacist and an experienced pharmacovigilance manager in the clinical trial setting. Besides his pharmacy degree, he has a dual master’s degree in public health and European public health with a focus on pharmacoepidemiology from Hamburg University of Applied Sciences, Germany.